Eurofins Bioanalytical Services, a provider of large molecule bioanalytical testing has announced that Jennifer Ohayon, PhD has joined the company as a Scientific Director for large molecule bioanalysis based at the company's St Charles, MO facility.
Dr. Ohayon will serve as a scientific and technical advisor for clients and internal teams for development, validation, and application of assays to ensure compliance with scientific and technical goals and regulatory requirements. She will also drive new technology and services strategy, and lead client development programs with a focus on expanding the large molecule bioanalysis capabilities and customer base.
"Jennifer's proven scientific leadership experience is a great addition for Eurofins Bioanalytical Services and our clients" said Dr.Jim Hulse, General Manager of Eurofins Bioanalytical Services." Jennifer brings a unique set of experiences that will enhance understanding of our clients' needs so we can continue to build strong relationships with our clients focusing on performance and transparency".
Dr. Ohayon's distinguished scientific career has held positions of increasing responsibility within the biopharmaceutical industry. After receiving her PhD from Indiana University, and completing her doctoral research at Harvard Medical School at the Joslin Diabetes Center, Dr. Ohayon held post-doctoral positions at the Memorial Sloan-Kettering Cancer Center and Rockefeller University. Most recently, Dr. Ohayon was the Director of R&D at Davita Healthcare Partners and then at Enzo Clinical labs as the Director of Clinical Operations and R&D. An accomplished leader in the field of bioanalysis, she has been involved in various industry organizations, including the American Association of Clinical Chemistry and the College of American Pathologists and as an invited speaker at multiple industry events.
Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.